|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.5 TWD | -0.62% |
|
+0.21% | -13.84% |
| Mar. 14 | Panion & Bf Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 07 | Panion & Bf Biotech Inc. Approves Cash Dividend for 2023 | CI |
Panion & Bf Biotech Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 1,881.88 million compared to TWD 2,398.65 million a year ago. Net income was TWD 77.22 million compared to TWD 182.35 million a year ago.
Basic earnings per share from continuing operations was TWD 0.9 compared to TWD 2.13 a year ago. Diluted earnings per share from continuing operations was TWD 0.9 compared to TWD 2.12 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.84% | 254M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PANION & BF BIOTECH INC. 
